» Articles » PMID: 37262021

A Nod to the Bond Between NOD2 and Mycobacteria

Overview
Journal PLoS Pathog
Specialty Microbiology
Date 2023 Jun 1
PMID 37262021
Authors
Affiliations
Soon will be listed here.
Abstract

Mycobacteria are responsible for several human and animal diseases. NOD2 is a pattern recognition receptor that has an important role in mycobacterial recognition. However, the mechanisms by which mutations in NOD2 alter the course of mycobacterial infection remain unclear. Herein, we aimed to review the totality of studies directly addressing the relationship between NOD2 and mycobacteria as a foundation for moving the field forward. NOD2 was linked to mycobacterial infection at 3 levels: (1) genetic, through association with mycobacterial diseases of humans; (2) chemical, through the distinct NOD2 ligand in the mycobacterial cell wall; and (3) immunologic, through heightened NOD2 signaling caused by the unique modification of the NOD2 ligand. The immune response to mycobacteria is shaped by NOD2 signaling, responsible for NF-κB and MAPK activation, and the production of various immune effectors like cytokines and nitric oxide, with some evidence linking this to bacteriologic control. Absence of NOD2 during mycobacterial infection of mice can be detrimental, but the mechanism remains unknown. Conversely, the success of immunization with mycobacteria has been linked to NOD2 signaling and NOD2 has been targeted as an avenue of immunotherapy for diseases even beyond mycobacteria. The mycobacteria-NOD2 interaction remains an important area of study, which may shed light on immune mechanisms in disease.

Citing Articles

Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia.

Greenblatt C, Lathe R J Alzheimers Dis. 2024; 98(2):361-372.

PMID: 38393913 PMC: 10977380. DOI: 10.3233/JAD-231323.


Vaccines and Dementia: Part I. Non-Specific Immune Boosting with BCG: History, Ligands, and Receptors.

Greenblatt C, Lathe R J Alzheimers Dis. 2024; 98(2):343-360.

PMID: 38393912 PMC: 10977417. DOI: 10.3233/JAD-231315.


Infectious Complications of Pulmonary Sarcoidosis.

Valeyre D, Bernaudin J, Brauner M, Nunes H, Jeny F J Clin Med. 2024; 13(2).

PMID: 38256476 PMC: 10816300. DOI: 10.3390/jcm13020342.

References
1.
Arts R, Blok B, Aaby P, Joosten L, de Jong D, van der Meer J . Long-term in vitro and in vivo effects of γ-irradiated BCG on innate and adaptive immunity. J Leukoc Biol. 2015; 98(6):995-1001. DOI: 10.1189/jlb.4MA0215-059R. View

2.
Guan R, Roychowdhury A, Ember B, Kumar S, Boons G, Mariuzza R . Structural basis for peptidoglycan binding by peptidoglycan recognition proteins. Proc Natl Acad Sci U S A. 2004; 101(49):17168-73. PMC: 535381. DOI: 10.1073/pnas.0407856101. View

3.
Srivastava M, Meinders A, Steinwede K, Maus R, Lucke N, Buhling F . Mediator responses of alveolar macrophages and kinetics of mononuclear phagocyte subset recruitment during acute primary and secondary mycobacterial infections in the lungs of mice. Cell Microbiol. 2006; 9(3):738-52. DOI: 10.1111/j.1462-5822.2006.00824.x. View

4.
Netea M, Azam T, Lewis E, Joosten L, Wang M, Langenberg D . Mycobacterium tuberculosis induces interleukin-32 production through a caspase- 1/IL-18/interferon-gamma-dependent mechanism. PLoS Med. 2006; 3(8):e277. PMC: 1539091. DOI: 10.1371/journal.pmed.0030277. View

5.
Schaefer A, Melnyk J, Baksh M, Lazor K, Finn M, Grimes C . Membrane Association Dictates Ligand Specificity for the Innate Immune Receptor NOD2. ACS Chem Biol. 2017; 12(8):2216-2224. PMC: 5569645. DOI: 10.1021/acschembio.7b00469. View